GPX4 in triple-negative breast cancer: A key regulator of ferroptosis and therapeutic target. (PubMed, Cancer Genet) - Jul 4, 2025 - "Ferroptosis inducers like erastin may help make TNBC cells more sensitive to treatment, but they are still hard to deliver because they are toxic and don't dissolve well...Exosomes are a new way to deliver drugs that cause ferroptosis because they are biocompatible and can target specific cells. This is a very interesting area for developing new treatments for TNBC."
Journal • Review • Breast Cancer • HER2 Breast Cancer • HER2 Positive Breast Cancer • Hormone Receptor Breast Cancer • Oncology • Solid Tumor • Triple Negative Breast Cancer • ER • GPX4 • HER-2 • PGR
|